Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is InSilico Medicine Cayman TopCo Cash Ratio?
InSilico Medicine Cayman TopCoISLMF -1.77%13 Cash Ratio is 13.20 as of Dec. 2025, which is 4977% above its 10-year median of 0.26. GuruFocus rates ISLMF with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 2,746 Software companies, InSilico Medicine Cayman TopCo ranks better than 98.11% on this metric.
InSilico Medicine Cayman TopCo has a Cash Ratio of 13.20. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for InSilico Medicine Cayman TopCo's Cash Ratio or its related term are showing as below:
ISLMF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.26 Max: 13.2
Current: 13.2
During the past 4 years, InSilico Medicine Cayman TopCo's highest Cash Ratio was 13.20. The lowest was 0.16. And the median was 0.26.
ISLMF's Cash Ratio is ranked better than 98.11% of 2746
companies
in the Software industry
Industry Median: 0.76
vs ISLMF: 13.20
InSilico Medicine Cayman TopCo (OTCPK:ISLMF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
InSilico Medicine Cayman TopCo Cash Ratio Related Terms
InSilico Medicine Cayman TopCo Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Infrastructure subindustry, InSilico Medicine Cayman TopCo's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InSilico Medicine Cayman TopCo Cash Ratio vs Software Industry
For the Software industry and Technology sector, InSilico Medicine Cayman TopCo's Cash Ratio distribution charts can be found below:
* The bar in red indicates where InSilico Medicine Cayman TopCo's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InSilico Medicine Cayman TopCo (ISLMF) has a Cash Ratio of 13.20 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on InSilico Medicine Cayman TopCo and its competitors. This is 4977% above median its historical median of 0.26. Over the past decade, InSilico Medicine Cayman TopCo's Cash Ratio has ranged from 0.16 to 13.20. According to the industry distribution chart, InSilico Medicine Cayman TopCo ranks #52 out of 2746 companies in the Software industry, placing it in the top 1.9%.
Is InSilico Medicine Cayman TopCo's Cash Ratio too high?
InSilico Medicine Cayman TopCo's current Cash Ratio of 13.20 is 4977% above median its 10-year median of 0.26. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 13.20. The Software industry median Cash Ratio is 0.76. InSilico Medicine Cayman TopCo's value of 13.20 is 1636.8% above this industry median. Based on the distribution chart, InSilico Medicine Cayman TopCo ranks #52 out of 2746 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, InSilico Medicine Cayman TopCo has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does InSilico Medicine Cayman TopCo's Cash Ratio compare to ?
According to the Software industry distribution chart, InSilico Medicine Cayman TopCo ranks #52 out of 2746 companies for Cash Ratio. This places InSilico Medicine Cayman TopCo in the top 2% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.76. InSilico Medicine Cayman TopCo's value of 13.20 is 1636.8% above this benchmark. Historically, InSilico Medicine Cayman TopCo's own Cash Ratio has ranged from 0.16 to 13.20 over the past decade. While the company's 10-year median is 0.26 vs. the industry median of 0.76, InSilico Medicine Cayman TopCo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Software company?
The median Cash Ratio among Software companies is 0.76, based on 2,746 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InSilico Medicine Cayman TopCo's current Cash Ratio of 13.20 is 1636.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on InSilico Medicine Cayman TopCo and its competitors. For the Software industry, the median Cash Ratio is 0.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InSilico Medicine Cayman TopCo's current Cash Ratio is 13.20, which is 4977% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InSilico Medicine Cayman TopCo stock overvalued right now?
InSilico Medicine Cayman TopCo (ISLMF) has a current Cash Ratio of 13.20. The current Cash Ratio is 13.20, which is 4977% above median its 10-year median of 0.26 and 1636.8% above the Software industry median of 0.76. InSilico Medicine Cayman TopCo's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For InSilico Medicine Cayman TopCo (ISLMF), the current Cash Ratio is 13.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. It has generated multiple clinical-stage or IND-enabling assets using Pharma.AI, an AI-enabled platform that supports drug discovery and development activities. The company operates under a project-based business model, deriving revenue from out-licensing and collaboration arrangements. Geographically, the company generates revenue from multiple countries, with the majority of the revenue coming from United States.
13GF Score
Get the complete analysis for ISLMF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISLMF has been successfully added to your 
